Coenzyme Q10 and Selenium in Heart Failure – A New Perspective

1. Senni M Gavazzi A, Oliva F et al. IN-HF Outcome investigators. In Hospital and 1 Year outcomes of acute heart failure patients according to presentation (de novo vs worsening) and ejection fraction. Results from IN-HF Outcome Registry. Int J Cardiol 2014; 173: 163-169Search in Google Scholar

2. Taylor C, Ordonez-Mena J, Roalfe A et al. Trends in survival after diagnosis of heart failure in the United Kingdom 2000-2017: population-based cohort study. BMJ 2019; 364/bmj.122310.1136/bmj.l223637292130760447Search in Google Scholar

3. Vaduganathan M, Butler J, Pitt B, Gheorghiade M.Contemporary Drug Developement in Heart Failure-Call for hemodynamically neutral Therapies. Circ Heart Fail 2015;8:826-83110.1161/CIRCHEARTFAILURE.115.00227126199309Search in Google Scholar

4. Rodrigues P, Leite-Moreira, Falcao-Pires I. Myocardial Reverse Remodelling: how far can we rewind? Am j Physiol Heart Circ Physiol 2106;310:H1402-142210.1152/ajpheart.00696.201526993225Search in Google Scholar

5. Senni M, Gavazzi A, Gheorghiade M et al. Heart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart. European Journal of Heart Failure (2015) 17: 760-76310.1002/ejhf.31526179815Search in Google Scholar

6. Kiyuna L, Prestes e Albuquerque R et al. Targeting mitochondrial dysfunction and oxidative stress in heart failure: challenges and opportunities Free Radic Biol Med 2018;129: 155-168Search in Google Scholar

7. Palaniyandi SS, Qi X et al. Regulation of mitochondrial processes: A target for heart failure, Drug Discov Today Dis Mech 2010; 7 1-1410.1016/j.ddmec.2010.07.002302628621278905Open DOISearch in Google Scholar

8. Figueira TR, Barros MH et al. Mitochondria as a Source of Reactive Oxygen and Nitrogen Species: From Molecular Mechanisms to Human Health, Antioxid.Redox Signal. 2013; 18 2029-207410.1089/ars.2012.472923244576Search in Google Scholar

9. Voulgaridou G, Anestopoulos I et al; DNA damage induced by endogenous aldehydes: current state of knowledge. Mutat Res. 2011; 711:13-2710.1016/j.mrfmmm.2011.03.00621419140Search in Google Scholar

10. Tsutsui H, Kinugawa S, Matsushima S. oxidative stress and heart failure. Am J Physiol Heart Circ Physiol. 2011;6 H2181-9010.1152/ajpheart.00554.201121949114Search in Google Scholar

11. Munzel T, Keaney JF et al Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications. Eur.Heart J 2015; 36:2555-2564Search in Google Scholar

12. Paulus WJ, Tschope C et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014; 515:431-43510.1038/nature13909425524225383517Search in Google Scholar

13. Sharma A, Fonarow G et al. Coenzyme Q10 and Heart Failure – A State of Art Review. Circ Heart Fail 2016; 9:e00263910.1161/CIRCHEARTFAILURE.115.00263927012265Search in Google Scholar

14. Crane F, Lester Y Widmer C. Isolation of a quinone from beef heart mitochondria. 1957 Biochimicaet Biophysica Acta. 25: 220-22110.1016/0006-3002(57)90457-2Search in Google Scholar

15. Herz N. Heart Healthy Seniors. Forlaget Ny Videnskab. www.healthscience.eu ISBN87-7776-107-3Search in Google Scholar

16. Folkers K, Littaru G et al. Evidence for a deficiency of coenzyme Q10 in human heart disease. International Journal of Vitamin Research. 1970;40(3):380-390Search in Google Scholar

17. Littaru G, Ho L, Folkers K. Deficiency of coenzyme Q10 in human disease. International Journal for Vitamin and Nutrition Research.1972; 42(2): 291-305Search in Google Scholar

18. Littaru G, Ho L, Folkers K. Deficiency of coenzyme Q10 in human disease. International Journal for Vitamin and Nutrition Research. 1972;42(3): 413-434Search in Google Scholar

19. Mitchell P. the protonmotive Q cycle: A general formulation. FEBS letters 1975; 59: 137-139. https://doi.org/10.1016/0014-5793(75)80359-010.1016/0014-5793(75)80359-0Open DOISearch in Google Scholar

20. Bentinger M, Brismar K et al. The antioxidant role of coenzyme Q. Mitochondrion. 2007; 7 suppl:S41-S5010.1016/j.mito.2007.02.00617482888Search in Google Scholar

21. Tsai K, Huang Y et al. A novel mechanism of coenzyme Q10 protects against human endothelial cells from oxidative stress-induced injury by modulating NO related pathways. J Nutr Biochem. 2012; 23: 458-46810.1016/j.jnutbio.2011.01.01121684136Search in Google Scholar

22. Marcoff L, Thompson PD. The role of coenzyme Q10 in statin-associated myopathy a systematic review. J Am Coll Cardiol. 2007;49:2231-3710.1016/j.jacc.2007.02.04917560286Search in Google Scholar

23. Alehagen U, Johansson P et al. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: A 5-year prospective randomized double – blind placebo – controlled trial among elderly Swedish citizens. Int J Cardiol 2013; 167:1860-186610.1016/j.ijcard.2012.04.15622626835Search in Google Scholar

24. Mugoni V, Postel R et al. Ubiad 1 is an antioxidant enzyme that regulates eNOS activity by CoQ10 synthesis. Cell 2013;152: 504-51810.1016/j.cell.2013.01.013357419523374346Search in Google Scholar

25. Garjani A, Andalib S et al. Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat. Eur J Pharmacol 2011; 666: 135-14110.1016/j.ejphar.2011.04.06121570962Search in Google Scholar

26. De Blasio M, Huynh Ket al. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished P!3K signalling. Free Radic Biol Med 2015;87:1-4010.1016/j.freeradbiomed.2015.04.02825937176Search in Google Scholar

27. Folkers K, Vadhanavikit S et al. Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. Proc Natl Acad Sci USA. 1985;82 901-90410.1073/pnas.82.3.9013971553856239Search in Google Scholar

28. Molyneux S, Florkowski C et al. J Am Coll Cardiol 2008;52:1535-41Search in Google Scholar

29. McMurray J, Dunselman P et al. CORONA Study Group. Coenzyme Q10, rosuvastatin and clinical outcomes in heart failure: a pre-specified substudy of CORONA (Controlled Rosuvastatin Multinational Study in heart failure). J Am Cardiol.2010;56:1196-1204Search in Google Scholar

30. Pierce J, Mahoney D et al. Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose. BMJ cardiovasc. disord. 2018;18:L57(PubMed:29606104)10.1186/s12872-018-0796-2Search in Google Scholar

31. Soja A, Mortensen S. Treatment of congestive heart failure with coenzyme Q10 illuminated by a meta-analyses of clinical trials. Mol Aspects Med.1997;18:suppl:159-16810.1016/S0098-2997(97)00042-3Search in Google Scholar

32. Sander S, Coleman Cl et al. The impact of coenzyme qQ10 on systolic function in patients with chronic heart failure. J card Fail.2006; 464-47210.1016/j.cardfail.2006.03.007Search in Google Scholar

33. Fotino A, Thompson-Paul A et al. Effect of coenzyme Q10 supplementation on heart failure a meta-analysis. Am J Clin Nutr 2013; 97:268-2752322157710.3945/ajcn.112.040741Search in Google Scholar

34. Rosenfeld F, Hilton D et al. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Biofactors 2003;18:91-10010.1002/biof.5520180211Search in Google Scholar

35. Madmani M, Solaiman A et al. Coenzyme Q10 for heart failure. Cochrane Data-base Syst Rev 2013; 9: CD00868410.1002/14651858.CD008684.pub2Search in Google Scholar

36. Mortensen S, Rosenfeldt F et al. The effect of Coenzyme Q10 on morbidity and mortality in chronic heart failure. 2014;2: 641-64925282031Search in Google Scholar

37. Mortensen S. Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure: rationale, design and endpoints of „Q-symbio”- a multinational trial. Biofactors 2003;18: 79-8910.1002/biof.5520180210Search in Google Scholar

38. Kalen A Appelkvist E et al. Age-related changes in the lipid compositions of rat and human tissues. Lipids 1989;18: 579-58410.1007/BF02535072Open DOISearch in Google Scholar

39. Baggio E, Gandini R et al. Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. CoQ10 Drug Surveillance Investigators. Mol Aspects Med 1994;15 suppls287-s28910.1016/0098-2997(94)90040-XSearch in Google Scholar

40. Benstoem C, Goetzenich A et al. Selenium and its supplementation in cardiovascular disease-What do we know? Nutrients 2015;7:3094-118Search in Google Scholar

41. Oldfield J. Selenium: A historical perspective.2006: https://doi.org/10.1007/0-387-33827-6_110.1007/0-387-33827-6_1Open DOISearch in Google Scholar

42. Yang G ge K et al. Selenium related endemic disease and the daily requirement of humans World Rev.Nutr.Diet.1988.;55:98-15210.1159/0004155603287776Search in Google Scholar

43. Xu G, Wang S et al Further investigation on the role of selenium deficiency in the etiology and pathogenesis of Keshan disease. Biomed Environ sci. 1997;10:316-326Search in Google Scholar

44. Loscalzo J. Effects of nationwide addition of selenium to fertilizers on foods and animal and human health in Finland: From deficiency to optimal selenium status of the population. J Trace Elem Med Biol.2014;370:1756-60Search in Google Scholar

45. Bleys J, navas Acien Aet al Arch Intern Med. 2008;168:404-41010.1001/archinternmed.2007.7418299496Search in Google Scholar

46. Joseph J. Selenium and cardiometabolic health: inconclusive yet intriguing evidence. Am J Med.Sci. 2013;346:216-220Search in Google Scholar

47. Stoppe C, McDonald B et al. SodiUm SeleniTe Administration IN cardiac Surgery (SUSTAIN CSX-trial): study design of an international multicenter randomized double blind controlled trial of high dose sodium selenite administration in high risk cardiac surgical patients. Trials 2104; 15:33910.1186/1745-6215-15-339424764925169040Search in Google Scholar

48. Alehagen U, Aaseth J et al. Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: A validation of previous 10-year follow-up results of a prospective randomized double blind placebo-controlled trial in elderly. Plos ONE 2018; https://doi.org/10.1371/journal.phone.0193120Search in Google Scholar